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Increasing incidence and widespread dissemination of 
methicillin-resistant Staphylococcus aureus (MRSA) in 
hospitals in central Europe, with special reference to 
German hospitals 
Wo&ang Witte ', Michael Kresken', Christine Braulke' and Christa Cuny ' 
'Robert Koch Institute, Wernigerode Branch, Wernigerode, and 2Rhone Poulenc Rorer GmbH, 
Cologne, Germany 
Objective: to present data on prevalence and interregional spread of methicillin-resistant Staphylococcus aureus 
(MRSA) in Germany. 
Methods: A nationwide collection of MRSA isolates from nosocomial infections in 143 hospitals was established from 
isolates (n=4368) sent to a microbiological reference center during 1993-95. As chosen by distinguishable resistance 
phenotypes at each time of occurrence during the study period, 1830 isolates were subjected to molecular typing by 
means of Smal macrorestriction patterns, PCR for RNA gene spacer patterns, and PCR for patterns of DNA stretches 
flanked by the ERIC-2 sequence and flanked by Tn916 and ribosomal binding site. In addition, data from a multicenter 
study on the incidence of antibiotic resistance have been analyzed (32 centers, 637 S. aureus isolates). 
Results: In 1995 the prevalence of MRSA among S. aureus isolates was 8.7% overall in central Europe (including 
Germany), in comparison to 1.7% in 1990. From 1993 until now, a continuous interregional dissemination of six epidemic 
strains, which were identified by molecular typing, was recorded. Besides these epidemic strains, 15 MRSA strains were 
identified which could not be allocated to the epidemic MRSA or to the known clonal groups of the species S. aureus. 
MRSA from three cases of sporadic nosocomial infections exhibited characteristics of the clonal group of S. aureus with 
the capacity for toxic shock syndrome formation. The pattern of one MRSA corresponded to those of the S. aureus group 
exhibiting phage pattern 94,96. 
Conclusions: The prevalence of MRSA has increased in central Europe (and Germany) during the last 5 years, to 8.7%. 
The main source of infection with MRSA is obviously interregional dissemination of epidemic strains. At the same time, 
the mecA gene has been acquired by strains previously sensitive to methicillin. 
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INTRODUCTION 
Methicillin-resistant Staphylococcus aureus (MRSA) 
presents a major problem in hospital infection and 
infection control because of resistance to multiple 
antibiotics. Furthermore, there are particular strains 
with an evident capacity for spread once introduced 
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into a hospital. As already indicated by conventional 
typing, interregional dissemination has been observed 
with distinct MRSA strains (EMRSA) in British 
hospitals [l]. Although a multicenter study in 1990 
revealed a relatively low incidence of MRSA in 
German hospitals [2], we have previously observed 
interregional clonal dmemination of two clearly 
distinguishable strains of MRSA in Germany [3],  one 
mainly in the south and the other mainly in the north. 
The related isolates were identified by SmaI macro- 
restriction patterns. At the beginning of 1994, s i x  
different MRSA strains were observed [4]. This paper 
describes the current prevalence of MRSA among 
S. aureus isolates in central Europe (and Germany), 
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derived from the results of a surveillance study con- 
ducted in late 1995 by the Bacterial Resistance Study 
Group of the Paul Ehrlich Society for Chemotherapy. 
In addition, we have analyzed the interregional dis- 
semination of MRSA in Germany on the basis of 
genomic typing. 
MATERIALS AND METHODS 
Surveillance study 
In November 1995, the Bacterial Resistance Study 
Group of the Paul Ehrlich Society for Chemotherapy 
conducted a surveillance study of the prevalence of 
antimicrobial resistance in central Europe. The study 
included 32 laboratories located in Austria (n=4), 
Germany ( ~ 2 ~ 2 1 )  and Switzerland (n=7). Each center 
was requested to collect 40 S. aureus isolates during 
October 1995, if available. No duplicate strains were 
allowed. All participating laboratories used the same 
standardized methods. Methods for identification of 
the S. aureus strains are described elsewhere [5]. Sus- 
ceptibility testing, using microdilution, was performed 
according to the guidelines recommended by the 
National Committee of Clinical Laboratory Standards 
[6] ,  with the exception that screening for S. aureus 
resistant to oxacillin was performed using Mueller- 
Hinton agar plates supplemented with 4% NaCl and 
6 mg/L oxacillin. 
Bacterial isolates (n=4368) 
MRSA from sporadic infections and from outbreaks in 
hospitals were sent to a national reference center for 
staphylococci. Strains were defined as MRSA by MIC 
24 mg/L for oxacillin and PCR demonstration of the 
mecA gene [4]. Of these isolates, 1830 were subjected 
to molecular typing. If in one of the affected hospitals 
(n=143) several isolates were obtained at a given point 
of time during the study period, molecular typing was 
performed for each distinguishable resistance pheno- 
type. S. aureus PS29 is the propagating strain for phage 
29 of the international basic set for phage typing 
staphylococci. 
Genomic DNA fragment patterns 
SmaI digestion and subsequent pulsed-field gel elec- 
trophoresis were performed as previously described [3]. 
PCR typing 
The protocols previously described for rRNA gene 
spacer patterns [7], for the length polymorphism of 
DNA sequences flanked by the Tn916 target region 
and ribosomal binding site (tar 916-shida PCR [S]), 
and for the length polymorphism of ERIC-2-flanked 
sequences [9], were followed. 
Documentation of macrorestriction patterns and similarity 
analysis 
Agarose gels were documented and image processed by 
the MWG-Biotech restriction fragment length poly- 
morphism scan system. Cluster analysis was derived 
from patterns of molecular masses of DNA fragments 
for each of the investigated strains which were stored 
in the databank system. This database is implemented 
in MS-Access version 2.0. The cluster analysis is based 
on an optimizing similarity algorithm [lo]. 
Current prevalence of MRSA in central Europe 
(and Germany) 
The surveillance study conducted in November 1995 
by the Bacterial Resistance Study Group of the Paul 
Ehrlich Society for Chemotherapy included 962 S. 
aureus strains. Based on the results of the MICs of 
oxacillin (resistant, MIC 24 mg/L) the overall pre- 
valence of MRSA in central Europe was 8.7% 
(Figure 1). Of the 637 S. aureus strains collected at the 
21 German laboratories participating in the study, 8.0% 
were MRSA. The agar screening test revealed slightly 
lower resistance rates, with 8.0% and 7.4% of strains 
found to be MRSA in central Europe and Germany, 
respectively. The study also investigated differences in 
the prevalence of MRSA between patient groups. Of 
158 isolates obtained from outpatients, 3.2% were 
MRSA; thus the predominant source of MRSA is the 
hospital. Furthermore, the prevalence of MRSA in 
intensive care units (13.5% of 148 isolates) is higher 
than that in other hospital units (9.0% of 654 isolates). 
Dissemination of MRSA 
Independently of the prevalence studies described above, 
after 1991 a network for surveillance of dissemination 
of MRSA in Germany was established based on contin- 
uous typing of MRSA from sporadic infections or from 
nosocomial outbreaks, which were isolated in designated 
local diagnostic laboratories (1 05 throughout Germany). 
Epidemic MRSA strains were named according to 
the geographic area of first recording, and include 
the northern German MRSA, the southern German 
MRSA, the Hannover area MRSA, the Berlin MRSA, 
the south eastern German western Austrian MRSA 
and the Vienna MRSA. For these strains, the possession 
of the mecA gene was evidenced by PCR. The resist- 
ance phenotypes of these strains are shown in Table 1. 
Molecular typing of MRSA was based on SmaI 
macrorestriction patterns which were image processed, 
stored in the databank and analyzed for similarity. 
Isolates exhibiting more than four different bands were 
regarded as different. A difference of four or more bands 
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corresponds to inore than one genetic event (mutation 
or rearrangements; for details see Tenover et a1 [l 11). 
The assignation of an isolate to one of the epidemic 
strains was confirmed by means of P C R  for different 
and independent DNA polymorphisms. That the six 
epidemic strains represent different strains has already 
been shown by SmaI macrorestriction patterns [4] and 
has been confirmed by tar 916-shida patterns (Figure 
2). The probable relatedness of the northern German 
MRSA and the Hannover area MRSA, the south 
eastern Germadwestern Austrian MRSA had been 
suggested previously by identical rRNA gene spacer 
patterns [4], and this is confirmed by ERIC-2 patterns 
(Figure 2). 
Table 1 Resistance phenotypes of epidemic M R S A  
MRSA denomination Antibiotics to which strain is resistance 
Northern German MRSA 
Southern German MKSA 
Hannover area MRSA 
South eastern Germadwestern Austrian MRSA 
Vienna MRSA 
Berlin MRSA 
PEN, OXA, GEN, ERY, CLI, OTE. SXT, RAM 
(FUS in 4 of 16 outbreak?) 
PEN, OXA, GEN, ERY, CLI, CIP, SXT 
PEN, OXA, GEN, ERY, CLI, OTE, CIP, SXT 
PEN, OXA, GEN, ERY, CLI, OTE, CIP, SXT 
PEN, OXA, GEN, ERY, CLI, OTE, CIP, SXT 
PEN, OXA, CIP (3 outbreaks) 
PEN, OXA, GEN, ERY, CLI, CIP (6 outbreaks) 
PEN, OXA, GEN, SXT (9 outbreaks) 
PEN, OXA, ERY, CLI, CIP (6 outbreaks) 
~ 
Abbreviations: PEN=petiicillin; OXA=oxacillm; C:EN=gentanicin; ERY =erythrornycln, CLI=clindaniycin; OTE=oxytetracycIine. 
CIP=ciprofloxacin, SXT=sulfonaniide-trimcthoprim, M = r i f a m p i c i n ,  FUS= fusidic acid. 
Figure 1 Prevalence of M R S A  among Staphylococcus aweux isolates in central Europe (and Germany) from 1976 to  1995. 
T h e  s tuhes performed between 1975 and 1984, and between 1990 and 1995, were conducted in cooperation with 
laboratories in Austria, Germany and Switzerland by the Bacterial Resistance Study Group of the Paul Ehrlich Society for 
Chemotherapy, and those performed in  1989 and 1992 were conducted with German hospitals by the study group of 
Knothe et a1 1121. 
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Figure 2 SmaI-macrorestriction patterns and PCR pattern of epidemic MRSA: A Berlin epidemic MRSA; *southern 
Gcrman epidemic MRSA; 0 northern German epidemic MRSA; 0 Hannover area epidemic MKSA; C3 southeastern 
Germadwestern Austrian epidemic MRSA; Vienna epidemic MKSA; S=S. a ~ r e u x  8325 as reference. 
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Figure 3 Interregional dissemination of multiply resistant 
and oxacillin-resistant S. aureus (MRSA) in Germany in 
1992 and 1993: Onorthern German epidemic strain; 
*southern German epidemic strain; A Berlin epidemic 
strain; 0 Hannover area epidemic strain; 0 southeastern 
Germadwestern Austrian epidenlic strain; IX Vienna 
epidemic strain. epidemic MRSA. 
Figure 4 Interregional dmemination of niultiply resistant 
and oxacillin-resistant S. aureus (MRSA) in Germany in 
1995 and 1996. ABerlin epidemic MRSA; *southern 
German epidenlic MRSA; 0 northern German epidemic 
MRSA; 0 Hannover area epidemic MRSA; 0 southeastern 
Gernxdwestern Austrian epidemic MRSA; Vienna 
Interregional spread of epidemic MRSA 
Figure 3 shows the distribution of occurrence of the 
northern German MRSA and the southern German 
MRSA by the end of 1993. At the end of 1995 (Figure 
4), the southern German MRSA had been found also 
in hospitals in the north of Germany and in Thuringia, 
and the northern German MRSA had been dis- 
seminated to the east. The Hannover area MRSA, 
which was observed in hospitals of Hannover and its 
vicinity in 1992, was also seen in hospitals in the 
western half of Germany. O f  special interest was the 
demonstration of the spread of the Berlin MRSA, 
which at the end of 1993 was present in six Berlin 
hospitals, but by the end of 1995 was present in 17 
Berlin hospitals, five hospitals in Brandenburg county, 
one hospital in Lower Saxony county and one hospital 
in Nordrhein-Westfalen county. The Vienna MRSA, 
which was isolated in nosocomial outbreaks in a 
number of Viennese hospitals in 1991-92, was seen at 
the end of 1995 in outbreaks ofinfection in six German 
hospitals. 
MRSA different from epidemic strains 
Besides outbreaks of infections by interregionally 
disseminated epidemic strains, MRSA with SmuI 
restriction patterns which were different from those of 
the epidemic strains by more than four fragments were 
observed in connection with infection in 15 German 
hospitals. SmuI macrorestriction patterns of these isolates 
(Figure 5) were compared to those of the epidemic 
strains described above and of reference strains of 
the major clonal groups within the species S. aureus 
by means of similarity analysis. The corresponding 
dendrogram is shown in Figure 6. This dendrogram 
also includes the patterns of reference strains for the 
major clonal groups within the species S. aureus as 
grouped by phage-typing patterns for historical reasons. 
According to this dendrogram, nine of these MRSA 
strains belong to the cluster of phage group 111 strains, 
which also includes the northern German MKSA, the 
Hannover area epidemic MRSA, the south eastern 
Germadwestern Austrian MRSA and the Vienna 
MRSA. The pattern of one strain was similar to those 
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of strains with phage pattern 94,96; and that of three 
strains resembled those of the clonal group of S.  a imus  
with the capacity for toxic shock syndrome toxin 
formation. That strains falling into the phage group I11 
cluster are probably related to the MRSA within this 
cluster is also indicated by rKNA gene spacer patterns, 
which were identical or similar to those of these strains 
(Figure 5). The MRSA belonging to the cluster of 
phage pattern 29 strains exhibited the same rRGS 
patterns as reference strain PS 29 (Figure 5). 
Smal macrorestriction pattern 
S=8325 as standard 
rRNA gene spacer pattern 
S=mol. mass standard 
Figure 5 SrtzaI nlacrorestrlctlon and rRNA gene spacer patterns of MKSA whlch are different from epidenuc MRSA. 
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Figure 6 Relatedness of SmaI macrorestriction patterns of MRSA which are different from those of epidemic strains: 
X, MRSA hfferent from epidemic strains; f, reference strains for clonal groups within the species S. aureus, (for symbols of 
epidemic MRSA, see Figure 2); 1, group of S. aureus exhibiting phage pattern 29, 52, +; 11, group of S. aureus exhibiting 
phage group I1 patterns; 111, group of S. aureus exhibiting phage group 111 patterns; IV, group of S. aureus exhibiting phage 
pattern 94, 96; V, group of S. aweus exhibiting phage pattern 95. 
DISCUSSION 
In this surveillance study conducted in  late 1995 by the 
Bacterial Resistance Study Group of the Paul Ehrlich 
Society for Chemotherapy, the prevalence of MRSA 
among S. uureus isolates was 8.7% in central Europe 
(and Germany). This rate was substantially higher than 
that recorded for MRSA in the previous surveillance 
study conducted i n  1990 (1.7%) [2] and those found in  
two German multicenter studies in  1989 (4.6%) and 
1992 (6.0%) by another study group [12]. Reviewing 
the data of all surveillance studies performed since 1976 
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by the Bacterial Kesistance Study Group, after 1984 
the prevalence of MRSA has increased from 1-2%) to 
8.7% in central Europe (and Germany), although the 
prevalence in 1990 was lower (Figure 1). The rate of 
8.7% MRSA, however, is still relatively low compared 
to the much higher resistance rates observed in 
southern Europe, where the proportion of MRSA has 
already exceeded 30% in some countries [2,13,14]. In 
recent studies, the proportion of MRSA among S. 
a u ~ c u s  from nosoconiial infections ranges from lower 
than 1%) in Denmark [I 51 and in The Netherlands [16] 
to 30% and even higher in Spain, Italy and France 
19,131. In the USA, the average frequency is 29% 1171. 
In parallel with the increasing incidence of MRSA 
up to 1995 in Germany, continuous interregional 
dissemination of epidemic MKSA was observed. The 
different strains exhibited characteristic patterns of 
DNA polyniorphisms with regard to .!ha1 fragments, 
rRNA gene spacers, DNA stretches flanked by ERIC- 
2 sequence or transposon 916 targ:et region and 
ribosomal binding site. 
MRSA strains from 15 hospitals were clearly dif- 
ferent from the epidemic strains by SmaI fragment 
patterns. Their allocation to distinct clonal groups of 
the species S. au~eus  was confirmed by rRNA gene 
spacer patterns (for rRNA gene spacer patterns of 
representative strains of S.  auyeus see Cuny et a1 [71). Of  
special interest was the occurrence of inethicillin resis- 
tance in groups of S. aureus which are also disseminated 
among the community and up to now have been 
sensitive to methicillin, such as those with phage pattern 
29, phage pattern 94,96 and phage pattern 95. 
Recent data from the USA [l8,19] and from 
Canada [20] suggest that circulation of MKSA in the 
community could be another source of interregional 
spread. As is evident from data on the origin of MRSA 
strains sent for typing to the authors’ laboratory in 1995 
(in which only three among 2500 isolates came from 
patients who had not been admitted to a hospital or 
nursing facility) and from a study in the Saarland federal 
county with the demonstration of five MRSA in nasal 
swabs from 1000 non-hospitalized patients (P. Rohr 
and W. Witte, unpublished), MRSA strains are obviously 
still rare among staphylococcal carriers outside hospitals 
in Germany. Nevertheless, this aspect requires further 
attention, especially with regard to the Berlin EMRSA, 
which has most probably originated from the clonal 
group of S. aweus with phage pattern 95 [4]. Recent 
data on the incidence of MRSA in Danish hospitals 
indicate that inter- and intrahospital spread of MRSA 
can, in principle, be prevented suces:ifully [14]. The 
results from Germany described in this communication 
suggest that besides the control measures for preventing 
the dissemination of MRSA (for details see Boyce 
et a1 [21]), iniprovenient in the information given to 
destination hospitals before transfer of patients with 
MRSA is necessary. 
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